Novira Therapeutics Lands $10,995,221 New Financing

  • Feed Type
  • Date
    8/23/2012
  • Company Name
    Novira Therapeutics
  • Mailing Address
    Undisclosed Los Angeles, CA 90041
  • Company Description
    Novira is an antiviral drug discovery company launched in 2009 that is focused on the discovery of novel, first-in-class therapeutics for the treatment of HBV and HIV, two global diseases in need of better therapies. The company is led by seasoned pharmaceutical industry executives with proven records of success in drug discovery. The company has identified and is further optimizing a promising pipeline of drugs that disrupt virus capsid assembly of HIV and HBV using an efficient and innovative model of biomedical research.
  • Website
    http://www.noviratherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,995,221
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.